Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.60 (
caspase-7
)
920
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Certain cell types undergo apoptosis when they lose integrin-mediated contacts with the extracellular matrix ("anoikis"). The Jun N-terminal kinase (JNK) pathway is activated in and promotes anoikis. This activation requires caspase activity. We presently report that a DEVD motif-specific caspase that cleaves
MEKK
-1 specifically is activated when cells lose matrix contact. This cleavage is required for the activation of the kinase activity. When overexpressed, the
MEKK
-1 cleavage product stimulates apoptosis; the wild-type, full-length
MEKK
-1 sensitizes cells to anoikis; and a cleavage-resistant mutant of
MEKK
-1 partially protects cells against anoikis. The cleavage-resistant or kinase-inactive mutants also prevent
caspase-7
from being activated completely. Thus, caspases can induce apoptosis by activating
MEKK
-1, which in turn activates more caspase activity, comprising a positive feedback loop.
...
PMID:The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. 924 5